Published in J Exp Med on July 01, 1981
Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). EMBO J (1984) 1.82
Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation. Mol Cell Biol (1987) 1.29
Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol (1991) 1.28
Thrombocytopoiesis--analysis by membrane tracer and freeze-fracture studies on fresh human and cultured mouse megakaryocytes. J Cell Biol (1984) 1.11
Chromosomal localization of the genes for the vitronectin and fibronectin receptors alpha subunits and for platelet glycoproteins IIb and IIIa. J Clin Invest (1988) 1.09
Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol Biol Cell (1996) 1.07
Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest (1989) 1.06
New synthesis of a platelet-specific protein: platelet factor 4 synthesis in a megakaryocyte-enriched rabbit bone marrow culture system. J Cell Biol (1983) 1.06
Antigenic differences between human platelets and megakaryocytes. Am J Pathol (1987) 0.93
Synergistic regulation of human megakaryocyte development. J Clin Invest (1988) 0.92
Pathophysiology and therapeutic options in primary immune thrombocytopenia. Blood Transfus (2010) 0.89
Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes. Haematologica (2012) 0.86
Thrombocytopenia in mice lacking the carboxy-terminal regulatory domain of the Ets transcription factor Fli1. Mol Cell Biol (2010) 0.85
Biosynthesis of factor V in isolated guinea pig megakaryocytes. J Clin Invest (1985) 0.85
The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis. Front Pediatr (2016) 0.79
Megakaryocytopoiesis in the human fetus. Arch Dis Child (1989) 0.79
A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes. Exp Hematol Oncol (2016) 0.75
"Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol (1966) 9.65
The pathogenesis of atherosclerosis (first of two parts). N Engl J Med (1976) 5.22
Localization of mouse isoantigens on the cell surface as revealed by immunofluorescence. Immunology (1967) 5.10
Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood (1980) 3.51
Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest (1977) 3.14
Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A (1974) 2.83
Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A (1977) 2.80
Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties. Scand J Immunol (1976) 2.74
Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest (1977) 2.43
Platelet physiology and abnormalities of platelet function (first of two parts). N Engl J Med (1975) 2.31
Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody. J Clin Invest (1980) 1.95
Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood (1973) 1.93
Membrane receptors of mouse leukocytes. II. Sequential expression of membrane receptors and phagocytic capacity during leukocyte differentiation. J Exp Med (1978) 1.69
Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med (1975) 1.43
Interrelationships of surface immunoglobulin and Fc receptors on mouse B lymphocytes. J Immunol (1975) 1.38
Isolation, purification, and partial characterization of platelet membrane glycoproteins IIb and IIIa. J Biol Chem (1981) 1.37
Inhibition of human erythropoietic colony formation in culture by treatment with Ia antisera. J Exp Med (1978) 1.32
Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med (1979) 1.31
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood (1981) 1.28
Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation. Br J Haematol (1978) 1.22
The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody. Br J Haematol (1978) 1.21
Immunofluorescent identification of human megakaryocyte colonies using an antiplatelet glycoprotein antiserum. Blood (1981) 1.19
Structural analysis of human platelet membrane glycoprotein I complex. Proc Natl Acad Sci U S A (1979) 1.18
Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand factor. Br J Haematol (1980) 1.14
Biology of megakaryocytes. Prog Hemost Thromb (1976) 1.03
Metabolic and functional studies of monocytes in congenital neutropenia. Br J Haematol (1974) 0.99
Reed-Sternberg cells in Hodgkin's disease contain fibronectin. Blood (1981) 0.96
Regulation of proliferation of murine megakaryocyte progenitor cells by cell cycle. Blood (1978) 0.93
Synthesis of actin by cultured guinea pig megakaryocytes. Complex formation with fibrin. Biochim Biophys Acta (1978) 0.90
The effect of platelet membrane antibodies on aggregation and release. Br J Haematol (1974) 0.89
Platelet factor VIII-related antigen: immunofluorescent localization. Thromb Res (1978) 0.88
Surface labelling as a tool to determine structure-function relationships of platelet plasma membrane glycoproteins. Thromb Haemost (1980) 0.87
Separation of megakaryocytes from mouse bone marrow by density gradient centrifugation. Blood (1976) 0.79
Thrombocytosis-induced suppression of small acetylcholinesterase-positive cells in bone marrow of rats. Blood (1979) 0.78
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest (1973) 10.18
Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest (1973) 5.31
Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med (1973) 4.46
A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest (1989) 3.71
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30
Isolation of the thrombospondin membrane receptor. J Clin Invest (1987) 2.87
Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A (1974) 2.83
A clinical study of the lupus anticoagulant. Blood (1976) 2.81
Contractile proteins of endothelial cells, platelets and smooth muscle. Am J Pathol (1973) 2.36
Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest (1982) 2.05
Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest (1982) 2.04
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med (1986) 2.01
Thrombospondin is the endogenous lectin of human platelets. Nature (1982) 1.98
Increased vascular permeability produced by human platelet granule cationic extract. J Clin Invest (1970) 1.98
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood (1995) 1.94
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood (1994) 1.90
Binding of plasminogen to cultured human endothelial cells. J Biol Chem (1986) 1.87
Role of thrombospondin in platelet aggregation. J Clin Invest (1984) 1.86
Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (1989) 1.85
Cancer and clotting--Trousseau's warning. N Engl J Med (1992) 1.78
Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody. J Exp Med (1986) 1.75
Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem (1973) 1.72
Membrane receptors of mouse leukocytes. II. Sequential expression of membrane receptors and phagocytic capacity during leukocyte differentiation. J Exp Med (1978) 1.69
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med (1986) 1.68
Rabbit platelet bactericidal protein. J Exp Med (1971) 1.63
The sequential appearance of Ia-like antigens and two different complement receptors during the maturation of human neutrophils. J Exp Med (1978) 1.56
Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells. J Clin Invest (1975) 1.56
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest (1987) 1.53
Drug purpura. Semin Hematol (1965) 1.53
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J Clin Invest (1984) 1.52
Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med (1987) 1.50
Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med (1975) 1.43
Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest (1984) 1.43
Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med (1998) 1.43
Binding of plasminogen to extracellular matrix. J Biol Chem (1986) 1.38
Functional mapping of the surface residues of human thrombin. J Biol Chem (1995) 1.38
Isolation, purification, and partial characterization of platelet membrane glycoproteins IIb and IIIa. J Biol Chem (1981) 1.37
Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem (1991) 1.36
In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood (1993) 1.36
Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun (1992) 1.32
Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest (1989) 1.32
Macrophage plasma membranes. I. Isolation and studies on protein components. J Exp Med (1971) 1.32
Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med (1979) 1.31
Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sci U S A (1986) 1.29
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood (1981) 1.28
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J Clin Invest (1987) 1.28
Immunoinhibition of ristocetin-induced platelet aggregation. J Clin Invest (1977) 1.26
Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood (1990) 1.26
The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes. J Biol Chem (1992) 1.24
Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J Clin Invest (1985) 1.24
The single-stranded DNA aptamer-binding site of human thrombin. J Biol Chem (1993) 1.23
Human platelet activation by C3a and C3a des-arg. J Exp Med (1983) 1.22
An extensive interaction interface between thrombin and factor V is required for factor V activation. J Biol Chem (2001) 1.20
Immunologic studies of proteins associated with subcellular fractions of normal human platelets. J Lab Clin Med (1967) 1.20
Characterization of human platelet vascular permeability-enhancing activity. J Clin Invest (1972) 1.20
Thrombospondin: a versatile multifunctional glycoprotein. Arteriosclerosis (1986) 1.19
Increased skin permeability in preterm infants. J Pediatr (1971) 1.18
Structural analysis of human platelet membrane glycoprotein I complex. Proc Natl Acad Sci U S A (1979) 1.18
Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation. J Biol Chem (1989) 1.18
Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry (1996) 1.17
Studies on human platelet protease activity. J Clin Invest (1969) 1.17
Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest (1987) 1.15
Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem (1996) 1.14
A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. Blood (1989) 1.14
Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study. J Exp Med (1981) 1.13
Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex. J Exp Med (1979) 1.13
Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. J Biol Chem (1985) 1.12
Cellular attachment to thrombospondin. Cooperative interactions between receptor systems. J Biol Chem (1991) 1.12
Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med (1998) 1.11
Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass. Ann Thorac Surg (1994) 1.09
Macrophage plasma membrane. II. Studies on synthesis and turnover of protein constituents. J Exp Med (1971) 1.08
Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest (2001) 1.08
Thrombocytopenia due to digitoxin. Demonstration of antibody and mechanisms of action. Am J Med (1966) 1.08
Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood (1997) 1.07
Studies on the proteins of human platelet membranes. J Biol Chem (1972) 1.06
Ultrastructure of thrombosthenin, the contractile protein of human blood platelets. Science (1967) 1.05
Human platelet membrane protein. Biochemistry (1970) 1.05
Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury. J Exp Med (1975) 1.04
The platelet as an inflammatory cell. Ann N Y Acad Sci (1972) 1.04
Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Invest (1986) 1.04
Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood (1983) 1.04
Receptors for C3 and IgG on macrophage, neutrophil and eosinophil colony cells grown in vitro. J Immunol (1975) 1.04